Elixinol Acquires 25% Stake in Pet Releaf
April 24, 2019
Elixinol purchased a 25% equity stake in Altmeds LLC, the maker of the Pet Releaf hemp‑derived CBD pet product line, to strengthen supply arrangements and provide growth capital to scale the business. The investment will fund working capital, new product lines and expansion of a new 25,000 sq. ft. production facility; Elixinol’s president will join the Pet Releaf board.
- Buyers
- Elixinol
- Targets
- Pet Releaf (Altmeds LLC)
- Sellers
- Alina and Steve Smith (founders of Pet Releaf)
- Industry
- Consumer Products
- Location
- Colorado, United States
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
Aurora Cannabis Acquires Reliva LLC
May 28, 2020
Consumer Products
Aurora Cannabis Inc. completed the acquisition of Reliva, LLC, a leading U.S. hemp-derived CBD consumer brand, in a transaction valued at approximately US$40 million in Aurora common shares plus an earn-out of up to US$45 million. The deal gives Aurora immediate U.S. retail CBD scale and distribution (Reliva products are sold in over 20,000 stores) and aims to combine Aurora's product innovation and international footprint with Reliva's U.S. retail relationships to accelerate growth.
-
Solmetex, LLC Acquires ReLeaf
January 13, 2026
Medical Devices
Solmetex, LLC has acquired ReLeaf, a developer of hands-free, high-volume evacuation systems for dental hygiene and clinical procedures, to expand its patient-safety and procedural-efficiency product portfolio. The acquisition will integrate ReLeaf's evacuation and aerosol-reduction technology into Solmetex's offerings and broaden accessibility to dental practices in the United States and Canada. Financial terms were not disclosed; Solmetex is PE-backed by investors including GTCR, AGIC Capital, Avista Healthcare Partners, and Gemini Investors.
-
High Tide Inc. Acquires 80% of NuLeaf Naturals
November 22, 2021
Consumer Products
High Tide Inc. has agreed to acquire an 80% stake in Denver-based NuLeaf Naturals for US$31.24 million, with a three-year option to buy the remaining 20%. The deal strengthens High Tide's vertical integration and global CBD capabilities by adding NuLeaf's cGMP-certified manufacturing, vegan softgel technology and D2C e-commerce distribution.
-
Curaleaf Holdings Acquires Minority Stake in Curaleaf International
July 2, 2025
Consumer Products
Curaleaf Holdings, Inc. completed the buyout of a single strategic institutional investor's equity stake in Curaleaf International Holdings Limited, bringing Curaleaf's ownership of its European holding company to 100%. The transaction was settled in Curaleaf subordinate voting shares and is intended to strengthen control and accelerate the company's strategic initiatives and expansion across European markets.
-
Aurora Cannabis Acquires Remaining Stake in MedReleaf Australia (Indica Industries)
February 8, 2024
Healthcare Services
Aurora Cannabis, through a wholly owned subsidiary, acquired the remaining ~90% equity interest in Indica Industries Pty Ltd (doing business as MedReleaf Australia) at an enterprise value of AUD$50 million. Consideration included AUD$9.45 million in cash and approximately 69.5 million Aurora common shares; MedReleaf Australia generated roughly AUD$40 million of trailing 12-month net revenue and holds the #2 position in the Australian medical cannabis market.
-
Bayou City Hemp Company Acquires LeafLife Wellness
June 18, 2020
Consumer Products
Bayou City Hemp Company, Inc., a Houston-based hemp processing and extraction company, has completed the acquisition of Leaf Life, Inc. (LeafLife Wellness), a Dallas-based CBD retail company that formulates, manufactures and distributes CBD-infused skincare, cosmetics and wellness products. The acquisition vertically integrates Bayou City Hemp’s supply chain—LeafLife will use Bayou City Hemp distillate and isolate—and expands the acquirer’s retail, white-label and online distribution capabilities; the deal is expected to be accretive to earnings.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.